Gilead Sciences (GILD) Shares Outstanding (2009 - 2026)

Gilead Sciences (GILD) has reported Shares Outstanding (Entity) for 18 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) changed 0.08% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (changed 0.08% YoY), and the FY2025 full-year result was $1.2 billion, changed 0.4% from the prior year.
• Shares Outstanding (Entity) held at $1.2 billion in Q2 2026 per GILD's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.3 billion in Q1 2022 and bottomed at $1.2 billion in Q4 2025.
• Historically, Shares Outstanding (Entity) has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
• The widest YoY moves for Shares Outstanding (Entity): up 0.08% in 2022, down 0.56% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $1.2 billion in 2022, then fell by 0.08% to $1.2 billion in 2023, then changed by 0.0% to $1.2 billion in 2024, then slipped by 0.4% to $1.2 billion in 2025, then changed by 0.0% to $1.2 billion in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.2 billion, $1.2 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.